MedicarePartD.guide

A non-government resource built from CMS public data

CDK4/6 inhibitors for breast cancer on every 2026 Connecticut Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 11 stand-alone Part D plans in Connecticut cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days

11 plans, cheapest premium first. Scroll sideways for all of them →

CDK4/6 inhibitors for breast cancer by 2026 Connecticut Part D plan
DrugHumana Basic Rx Plan$8.40/moS5884-102Wellcare Value Script$16.40/moS4802-137Blue MedicareRx Value Plus$20.70/moS2893-001Wellcare Classic$21.70/moS4802-076SilverScript Choice$32.70/moS5601-004AARP Medicare Rx Saver from UHC$38.70/moS5921-348Humana Value Rx Plan$73.60/moS5884-182Humana Premier Rx Plan$138.60/moS5884-149HealthSpring Assurance Rx$139.30/moS5617-008AARP Medicare Rx Preferred from UHC$155.10/moS5921-385Blue MedicareRx Premier$238.60/moS2893-003
IbrancepalbociclibTier 5PA25%QL 21/28dTier 5PA25%QL 21/28dTier 5PA25%QL 21/28dTier 5PA25%QL 21/28dTier 5PA25%QL 21/28dTier 5PA25%QL 21/21dTier 5PA26%QL 21/28dTier 5PA33%QL 21/28dTier 5PA25%QL 21/28dTier 5PA31%QL 21/21dTier 5PA33%QL 21/28d
KisqaliribociclibTier 5PA25%QL 21/28dTier 5PA25%QL 21/28dTier 5PA25%QL 21/28dTier 5PA25%QL 21/28dTier 5PA25%Tier 5PA25%QL 21/21dTier 5PA26%QL 21/28dTier 5PA33%QL 21/28dTier 5PA25%QL 21/28dTier 5PA31%QL 21/21dTier 5PA33%QL 21/28d
VerzenioabemaciclibTier 5PA25%QL 60/30dTier 5PA25%QL 56/28dTier 5PA25%QL 56/28dTier 5PA25%QL 56/28dTier 5PA25%Tier 5PA25%QL 56/28dTier 5PA26%QL 60/30dTier 5PA33%QL 60/30dTier 5PA25%QL 60/30dTier 5PA31%QL 56/28dTier 5PA33%QL 56/28d

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.